| answer text |
<p>NHS England and the National Institute for Health and Care Excellence are currently
consulting on draft proposals on the future direction of the Cancer Drugs Fund (CDF).
The consultation is open until 11 February 2016 and further information is available
at:</p><br /><p>www.engage.england.nhs.uk/consultation/cdf-consultation</p><br /><p>The
Accelerated Access Review independently chaired by Sir Hugh Taylor, is working with
key stakeholders on a range of options for accelerating patient access to innovative
products, as set out in the interim report. This includes consideration of the impact
of managed access schemes such as proposed in the CDF consultation.</p>
|
 |
